nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—polycystic ovary syndrome	0.318	0.405	CbGaD
Fluoxymesterone—AR—polycystic ovary syndrome	0.279	0.355	CbGaD
Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.189	0.241	CbGaD
Fluoxymesterone—ESR1—ovarian follicle—polycystic ovary syndrome	0.0111	0.16	CbGeAlD
Fluoxymesterone—PRLR—endometrium—polycystic ovary syndrome	0.00724	0.104	CbGeAlD
Fluoxymesterone—PRLR—uterus—polycystic ovary syndrome	0.00668	0.0957	CbGeAlD
Fluoxymesterone—PRLR—female gonad—polycystic ovary syndrome	0.00546	0.0783	CbGeAlD
Fluoxymesterone—NR3C1—urine—polycystic ovary syndrome	0.00344	0.0493	CbGeAlD
Fluoxymesterone—SHBG—endometrium—polycystic ovary syndrome	0.00156	0.0224	CbGeAlD
Fluoxymesterone—ESR1—embryo—polycystic ovary syndrome	0.00151	0.0216	CbGeAlD
Fluoxymesterone—SHBG—uterus—polycystic ovary syndrome	0.00144	0.0207	CbGeAlD
Fluoxymesterone—SHBG—pituitary gland—polycystic ovary syndrome	0.00142	0.0203	CbGeAlD
Fluoxymesterone—SHBG—adipose tissue—polycystic ovary syndrome	0.00141	0.0202	CbGeAlD
Fluoxymesterone—SHBG—adrenal gland—polycystic ovary syndrome	0.00126	0.0181	CbGeAlD
Fluoxymesterone—AR—adrenal cortex—polycystic ovary syndrome	0.00126	0.018	CbGeAlD
Fluoxymesterone—SHBG—female gonad—polycystic ovary syndrome	0.00118	0.0169	CbGeAlD
Fluoxymesterone—SHBG—vagina—polycystic ovary syndrome	0.00117	0.0168	CbGeAlD
Fluoxymesterone—AR—endometrium—polycystic ovary syndrome	0.00112	0.0161	CbGeAlD
Fluoxymesterone—NR3C1—embryo—polycystic ovary syndrome	0.00111	0.0159	CbGeAlD
Fluoxymesterone—ESR1—endometrium—polycystic ovary syndrome	0.0011	0.0158	CbGeAlD
Fluoxymesterone—SHBG—endocrine gland—polycystic ovary syndrome	0.0011	0.0157	CbGeAlD
Fluoxymesterone—AR—uterus—polycystic ovary syndrome	0.00103	0.0148	CbGeAlD
Fluoxymesterone—AR—pituitary gland—polycystic ovary syndrome	0.00102	0.0146	CbGeAlD
Fluoxymesterone—ESR1—uterus—polycystic ovary syndrome	0.00102	0.0146	CbGeAlD
Fluoxymesterone—AR—adipose tissue—polycystic ovary syndrome	0.00101	0.0145	CbGeAlD
Fluoxymesterone—ESR1—pituitary gland—polycystic ovary syndrome	0.000997	0.0143	CbGeAlD
Fluoxymesterone—ESR1—adipose tissue—polycystic ovary syndrome	0.000993	0.0142	CbGeAlD
Fluoxymesterone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000911	0.0131	CbGeAlD
Fluoxymesterone—AR—adrenal gland—polycystic ovary syndrome	0.000908	0.013	CbGeAlD
Fluoxymesterone—ESR1—adrenal gland—polycystic ovary syndrome	0.000891	0.0128	CbGeAlD
Fluoxymesterone—AR—female gonad—polycystic ovary syndrome	0.000846	0.0121	CbGeAlD
Fluoxymesterone—AR—vagina—polycystic ovary syndrome	0.000841	0.0121	CbGeAlD
Fluoxymesterone—ESR1—female gonad—polycystic ovary syndrome	0.000831	0.0119	CbGeAlD
Fluoxymesterone—ESR1—vagina—polycystic ovary syndrome	0.000826	0.0118	CbGeAlD
Fluoxymesterone—NR3C1—endometrium—polycystic ovary syndrome	0.000813	0.0117	CbGeAlD
Fluoxymesterone—AR—endocrine gland—polycystic ovary syndrome	0.000787	0.0113	CbGeAlD
Fluoxymesterone—ESR1—endocrine gland—polycystic ovary syndrome	0.000773	0.0111	CbGeAlD
Fluoxymesterone—NR3C1—uterus—polycystic ovary syndrome	0.000749	0.0107	CbGeAlD
Fluoxymesterone—NR3C1—pituitary gland—polycystic ovary syndrome	0.000736	0.0105	CbGeAlD
Fluoxymesterone—NR3C1—adipose tissue—polycystic ovary syndrome	0.000733	0.0105	CbGeAlD
Fluoxymesterone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000657	0.00942	CbGeAlD
Fluoxymesterone—NR3C1—female gonad—polycystic ovary syndrome	0.000613	0.00879	CbGeAlD
Fluoxymesterone—NR3C1—vagina—polycystic ovary syndrome	0.000609	0.00873	CbGeAlD
Fluoxymesterone—NR3C1—endocrine gland—polycystic ovary syndrome	0.00057	0.00817	CbGeAlD
Fluoxymesterone—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000459	0.0561	CrCbGaD
Fluoxymesterone—Dydrogesterone—PGR—polycystic ovary syndrome	0.000403	0.0493	CrCbGaD
Fluoxymesterone—Stanozolol—AR—polycystic ovary syndrome	0.000399	0.0487	CrCbGaD
Fluoxymesterone—Oxandrolone—AR—polycystic ovary syndrome	0.000359	0.0439	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000254	0.0311	CrCbGaD
Fluoxymesterone—Megestrol acetate—PGR—polycystic ovary syndrome	0.000243	0.0296	CrCbGaD
Fluoxymesterone—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.00024	0.0293	CrCbGaD
Fluoxymesterone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000224	0.0274	CrCbGaD
Fluoxymesterone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000168	0.0205	CrCbGaD
Fluoxymesterone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000166	0.0203	CrCbGaD
Fluoxymesterone—Fludrocortisone—AR—polycystic ovary syndrome	0.000164	0.02	CrCbGaD
Fluoxymesterone—Danazol—PGR—polycystic ovary syndrome	0.000157	0.0192	CrCbGaD
Fluoxymesterone—Spironolactone—PGR—polycystic ovary syndrome	0.000151	0.0184	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00015	0.00111	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—GAB1—polycystic ovary syndrome	0.000147	0.00109	CbGpPWpGaD
Fluoxymesterone—Danazol—SHBG—polycystic ovary syndrome	0.000147	0.018	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000147	0.00108	CbGpPWpGaD
Fluoxymesterone—Testosterone Propionate—AR—polycystic ovary syndrome	0.000146	0.0178	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.000143	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000143	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—BAX—polycystic ovary syndrome	0.000142	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000142	0.00105	CbGpPWpGaD
Fluoxymesterone—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000142	0.0174	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000141	0.00104	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000141	0.0173	CrCbGaD
Fluoxymesterone—Spironolactone—SHBG—polycystic ovary syndrome	0.000141	0.0172	CrCbGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00014	0.00104	CbGpPWpGaD
Fluoxymesterone—Norethindrone—PGR—polycystic ovary syndrome	0.00014	0.0171	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—YAP1—polycystic ovary syndrome	0.00014	0.00103	CbGpPWpGaD
Fluoxymesterone—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.00014	0.0171	CrCbGaD
Fluoxymesterone—AR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000138	0.00102	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000138	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—GAB1—polycystic ovary syndrome	0.000138	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000137	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000136	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—polycystic ovary syndrome	0.000136	0.001	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000136	0.001	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000135	0.000999	CbGpPWpGaD
Fluoxymesterone—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000135	0.0165	CrCbGaD
Fluoxymesterone—PRLR—Immune System—CAMK2D—polycystic ovary syndrome	0.000134	0.000987	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.000132	0.0161	CrCbGaD
Fluoxymesterone—Amcinonide—NR3C1—polycystic ovary syndrome	0.000132	0.0161	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000132	0.000975	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TNRC6B—polycystic ovary syndrome	0.000132	0.000972	CbGpPWpGaD
Fluoxymesterone—Norethindrone—SHBG—polycystic ovary syndrome	0.000131	0.016	CrCbGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000131	0.000964	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000131	0.000963	CbGpPWpGaD
Fluoxymesterone—Danazol—AR—polycystic ovary syndrome	0.000129	0.0158	CrCbGaD
Fluoxymesterone—Betamethasone—PGR—polycystic ovary syndrome	0.000128	0.0157	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000128	0.000947	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000127	0.000941	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000127	0.000938	CbGpPWpGaD
Fluoxymesterone—Mometasone—NR3C1—polycystic ovary syndrome	0.000126	0.0154	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000125	0.000921	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000124	0.000918	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000124	0.0152	CrCbGaD
Fluoxymesterone—Spironolactone—AR—polycystic ovary syndrome	0.000124	0.0151	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	0.000123	0.000911	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000123	0.000906	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PGR—polycystic ovary syndrome	0.000122	0.000902	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FST—polycystic ovary syndrome	0.000122	0.000897	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000121	0.000894	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—LEP—polycystic ovary syndrome	0.00012	0.000887	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00012	0.000886	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000119	0.00088	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000119	0.000879	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LHB—polycystic ovary syndrome	0.000119	0.000876	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000118	0.00087	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ADARB1—polycystic ovary syndrome	0.000118	0.000867	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000116	0.000856	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000116	0.000856	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000116	0.0142	CrCbGaD
Fluoxymesterone—PRLR—Immune System—ATF1—polycystic ovary syndrome	0.000116	0.000853	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000115	0.00085	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000112	0.000829	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SCT—polycystic ovary syndrome	0.000111	0.000821	CbGpPWpGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000111	0.0135	CrCbGaD
Fluoxymesterone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000111	0.0135	CrCbGaD
Fluoxymesterone—Progesterone—CYP17A1—polycystic ovary syndrome	0.00011	0.0134	CrCbGaD
Fluoxymesterone—Methyltestosterone—AR—polycystic ovary syndrome	0.000109	0.0133	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000109	0.000804	CbGpPWpGaD
Fluoxymesterone—Danazol—CYP19A1—polycystic ovary syndrome	0.000108	0.0132	CrCbGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IRS1—polycystic ovary syndrome	0.000107	0.000792	CbGpPWpGaD
Fluoxymesterone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000107	0.0131	CrCbGaD
Fluoxymesterone—PRLR—Immune System—TAB1—polycystic ovary syndrome	0.000107	0.000787	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000106	0.000786	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000106	0.000786	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000106	0.000783	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PRL—polycystic ovary syndrome	0.000106	0.00078	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000106	0.000779	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.000105	0.000775	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000105	0.000774	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000105	0.000774	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000104	0.000769	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000103	0.000763	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000103	0.00076	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000102	0.0125	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000102	0.000751	CbGpPWpGaD
Fluoxymesterone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000101	0.0123	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000101	0.0123	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000101	0.000742	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PRL—polycystic ovary syndrome	9.91e-05	0.000731	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP11A1—polycystic ovary syndrome	9.91e-05	0.0121	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	9.82e-05	0.000725	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	9.77e-05	0.000721	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—YAP1—polycystic ovary syndrome	9.65e-05	0.000712	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	9.6e-05	0.000708	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—LSM5—polycystic ovary syndrome	9.58e-05	0.000707	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	9.55e-05	0.000705	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GAB1—polycystic ovary syndrome	9.52e-05	0.000703	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	9.47e-05	0.000699	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—SHBG—polycystic ovary syndrome	9.37e-05	0.0114	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	9.27e-05	0.000684	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	9.17e-05	0.000676	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—CYP19A1—polycystic ovary syndrome	9.13e-05	0.0112	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—INSR—polycystic ovary syndrome	9.1e-05	0.000672	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ADARB1—polycystic ovary syndrome	9.05e-05	0.000668	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	8.92e-05	0.000658	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SAP30L—polycystic ovary syndrome	8.91e-05	0.000657	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL18—polycystic ovary syndrome	8.9e-05	0.000656	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	8.87e-05	0.000655	CbGpPWpGaD
Fluoxymesterone—Betamethasone—CYP19A1—polycystic ovary syndrome	8.81e-05	0.0108	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	8.75e-05	0.000646	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	8.74e-05	0.000645	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—NR3C1—polycystic ovary syndrome	8.71e-05	0.0106	CrCbGaD
Fluoxymesterone—PRLR—Immune System—NRG1—polycystic ovary syndrome	8.7e-05	0.000642	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.65e-05	0.000638	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.52e-05	0.000628	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PGR—polycystic ovary syndrome	8.43e-05	0.000622	CbGpPWpGaD
Fluoxymesterone—Spironolactone—NR3C1—polycystic ovary syndrome	8.39e-05	0.0102	CrCbGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	8.33e-05	0.000615	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	8.31e-05	0.000613	CbGpPWpGaD
Fluoxymesterone—Progesterone—PGR—polycystic ovary syndrome	8.17e-05	0.00997	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	8.15e-05	0.000602	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	8.14e-05	0.0006	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	7.96e-05	0.000587	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	7.92e-05	0.000584	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	7.86e-05	0.0096	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—GHRL—polycystic ovary syndrome	7.84e-05	0.000578	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLAT—polycystic ovary syndrome	7.84e-05	0.000578	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	7.79e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—Progesterone—SHBG—polycystic ovary syndrome	7.63e-05	0.00932	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	7.63e-05	0.000563	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TEAD2—polycystic ovary syndrome	7.57e-05	0.000559	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	7.52e-05	0.000555	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ATF1—polycystic ovary syndrome	7.48e-05	0.000552	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PGR—polycystic ovary syndrome	7.47e-05	0.00912	CrCbGaD
Fluoxymesterone—PRLR—Immune System—CRP—polycystic ovary syndrome	7.45e-05	0.00055	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS2—polycystic ovary syndrome	7.45e-05	0.00055	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	7.38e-05	0.000545	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.29e-05	0.000538	CbGpPWpGaD
Fluoxymesterone—Prednisolone—NR3C1—polycystic ovary syndrome	7.28e-05	0.0089	CrCbGaD
Fluoxymesterone—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	7.27e-05	0.000536	CbGpPWpGaD
Fluoxymesterone—Testosterone—SHBG—polycystic ovary syndrome	7.21e-05	0.00881	CrCbGaD
Fluoxymesterone—Betamethasone—NR3C1—polycystic ovary syndrome	7.14e-05	0.00872	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	6.98e-05	0.000515	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	6.92e-05	0.000511	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	6.92e-05	0.000511	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGFR—polycystic ovary syndrome	6.9e-05	0.000509	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	6.86e-05	0.000506	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PRL—polycystic ovary syndrome	6.84e-05	0.000505	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	6.8e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	6.76e-05	0.000499	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	6.74e-05	0.000498	CbGpPWpGaD
Fluoxymesterone—Progesterone—AR—polycystic ovary syndrome	6.69e-05	0.00817	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	6.64e-05	0.00049	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	6.56e-05	0.000484	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	6.52e-05	0.000481	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS1—polycystic ovary syndrome	6.5e-05	0.00048	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.49e-05	0.000479	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	6.43e-05	0.000475	CbGpPWpGaD
Fluoxymesterone—Testosterone—AR—polycystic ovary syndrome	6.33e-05	0.00773	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	6.3e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	6.13e-05	0.000452	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	6.11e-05	0.000451	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	6.1e-05	0.00045	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT2—polycystic ovary syndrome	6.02e-05	0.000444	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNAS—polycystic ovary syndrome	6.01e-05	0.000444	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	5.98e-05	0.000442	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	5.83e-05	0.00043	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	5.79e-05	0.000427	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	5.74e-05	0.000424	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.73e-05	0.000423	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	5.7e-05	0.000421	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	5.64e-05	0.000416	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRG1—polycystic ovary syndrome	5.62e-05	0.000415	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—NR3C1—polycystic ovary syndrome	5.57e-05	0.0068	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	5.44e-05	0.000401	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL37A—polycystic ovary syndrome	5.4e-05	0.000398	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	5.33e-05	0.000393	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP19A1—polycystic ovary syndrome	5.3e-05	0.00647	CrCbGaD
Fluoxymesterone—PRLR—Immune System—BCL2—polycystic ovary syndrome	5.26e-05	0.000388	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP19A1—polycystic ovary syndrome	5.12e-05	0.00626	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	5.06e-05	0.000373	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	4.98e-05	0.000367	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	4.96e-05	0.000366	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS2—polycystic ovary syndrome	4.82e-05	0.000355	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	4.81e-05	0.000355	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	4.8e-05	0.000354	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	4.74e-05	0.00035	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—polycystic ovary syndrome	4.71e-05	0.000348	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.7e-05	0.000347	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	4.69e-05	0.000346	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	4.67e-05	0.000345	CbGpPWpGaD
Fluoxymesterone—Progesterone—NR3C1—polycystic ovary syndrome	4.54e-05	0.00554	CrCbGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	4.46e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS1—polycystic ovary syndrome	4.21e-05	0.00031	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	4.19e-05	0.000309	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	4.16e-05	0.000307	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—NR3C1—polycystic ovary syndrome	4.15e-05	0.00507	CrCbGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	4.13e-05	0.000305	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP1A1—polycystic ovary syndrome	4.12e-05	0.00503	CrCbGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	4.12e-05	0.000304	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.11e-05	0.000303	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	4.09e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—polycystic ovary syndrome	4.05e-05	0.000299	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—polycystic ovary syndrome	4.03e-05	0.000297	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.99e-05	0.000294	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	3.93e-05	0.00029	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP1A1—polycystic ovary syndrome	3.9e-05	0.00476	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—polycystic ovary syndrome	3.9e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT2—polycystic ovary syndrome	3.89e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	3.87e-05	0.000286	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.79e-05	0.00028	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP1A1—polycystic ovary syndrome	3.77e-05	0.0046	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	3.71e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.7e-05	0.000273	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—YAP1—polycystic ovary syndrome	3.62e-05	0.000267	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.56e-05	0.000263	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.5e-05	0.000258	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.5e-05	0.000258	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.44e-05	0.000254	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.38e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.27e-05	0.000242	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.24e-05	0.000239	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.2e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	3.19e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	3.18e-05	0.000235	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.18e-05	0.000235	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—polycystic ovary syndrome	3.16e-05	0.000233	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.09e-05	0.000228	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.07e-05	0.000227	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	3.01e-05	0.000222	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.88e-05	0.000213	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	2.85e-05	0.00021	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.81e-05	0.000208	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	2.79e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	2.75e-05	0.000203	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—polycystic ovary syndrome	2.72e-05	0.000201	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	2.56e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	2.55e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.54e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.46e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.46e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	2.46e-05	0.000181	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—polycystic ovary syndrome	2.43e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.43e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	2.42e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.41e-05	0.000178	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	2.4e-05	0.000177	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.34e-05	0.000173	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	2.28e-05	0.000168	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.26e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	2.23e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.22e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.19e-05	0.000161	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.18e-05	0.000161	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOR1—polycystic ovary syndrome	2.15e-05	0.000158	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.11e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	2.09e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.99e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—polycystic ovary syndrome	1.99e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	1.96e-05	0.000144	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	1.94e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AR—polycystic ovary syndrome	1.89e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	1.86e-05	0.000138	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	1.81e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	1.79e-05	0.000132	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—polycystic ovary syndrome	1.76e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	1.71e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	1.65e-05	0.000122	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	1.63e-05	0.00012	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.62e-05	0.00012	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.6e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	1.58e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.54e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	1.53e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.47e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.47e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.4e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.39e-05	0.000102	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.37e-05	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.3e-05	9.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	1.28e-05	9.47e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.22e-05	8.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	1.19e-05	8.75e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.17e-05	8.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.08e-05	7.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.07e-05	7.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.06e-05	7.79e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.05e-05	7.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.05e-06	6.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	8.85e-06	6.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.9e-06	5.83e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	7.6e-06	5.61e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	7.56e-06	5.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.31e-06	5.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.31e-06	5.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.95e-06	5.13e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.78e-06	3.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	3.3e-06	2.44e-05	CbGpPWpGaD
